BRPI0519199A2 - composiÇço de viscossuplemento e uso da mesma - Google Patents

composiÇço de viscossuplemento e uso da mesma

Info

Publication number
BRPI0519199A2
BRPI0519199A2 BRPI0519199-8A BRPI0519199A BRPI0519199A2 BR PI0519199 A2 BRPI0519199 A2 BR PI0519199A2 BR PI0519199 A BRPI0519199 A BR PI0519199A BR PI0519199 A2 BRPI0519199 A2 BR PI0519199A2
Authority
BR
Brazil
Prior art keywords
composition
viscossuplement
viscossuplementos
compositions
release
Prior art date
Application number
BRPI0519199-8A
Other languages
English (en)
Inventor
Guohua Chen
Edwin Chan
Joe Rosenblatt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of BRPI0519199A2 publication Critical patent/BRPI0519199A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

COMPOSIÇçO DE VISCOSSUPLEMENTO E USO DA MESMA. A presente invenção refere-se a métodos e composições de depósito de emulsão para a liberação de viscossuplementos.
BRPI0519199-8A 2004-12-23 2005-12-20 composiÇço de viscossuplemento e uso da mesma BRPI0519199A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63853504P 2004-12-23 2004-12-23
US11/305,939 US20060140988A1 (en) 2004-12-23 2005-12-19 Visco-supplement composition and methods
PCT/US2005/046446 WO2006071694A1 (en) 2004-12-23 2005-12-20 Visco-supplement composition and methods

Publications (1)

Publication Number Publication Date
BRPI0519199A2 true BRPI0519199A2 (pt) 2008-12-30

Family

ID=36169128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519199-8A BRPI0519199A2 (pt) 2004-12-23 2005-12-20 composiÇço de viscossuplemento e uso da mesma

Country Status (14)

Country Link
US (1) US20060140988A1 (pt)
EP (1) EP1827376A1 (pt)
JP (1) JP2008525471A (pt)
KR (1) KR20070091302A (pt)
AR (1) AR052182A1 (pt)
AU (1) AU2005322231A1 (pt)
BR (1) BRPI0519199A2 (pt)
CA (1) CA2587388A1 (pt)
IL (1) IL184062A0 (pt)
MX (1) MX2007007826A (pt)
NO (1) NO20073762L (pt)
RU (1) RU2007127835A (pt)
TW (1) TW200640496A (pt)
WO (1) WO2006071694A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2282529T3 (es) * 2003-02-03 2007-10-16 Hans-Dietrich Dr.Techn. Polaschegg Composicion para la prevencion de una infeccion debida a un dispositi vo permanente.
UY33517A (es) * 2010-07-19 2012-02-29 Astrazeneca Ab Depósito farmacéutico para 5-fluoro-2-[[(1S)-1-(5-fluoro-2-piridil)etil]amino]-6-[(5-isopropoxi-1H-pirazol-3-il)amino]piridin-3-carbonitrilo?.
WO2013076162A1 (en) 2011-11-21 2013-05-30 Université Libre de Bruxelles Formulations useful in the treatment of osteoarticular diseases
US10245306B2 (en) * 2012-11-16 2019-04-02 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
WO2015018461A1 (fr) 2013-08-09 2015-02-12 Genbiotech Compositions therapeutiques comprenant d'acide hyaluronique
US10179191B2 (en) 2014-10-09 2019-01-15 Isto Technologies Ii, Llc Flexible tissue matrix and methods for joint repair
EP3237013B1 (en) 2014-12-23 2023-06-07 Steven Hoffman Transdermal formulations
IT201800007683A1 (it) 2018-07-31 2020-01-31 Altergon Sa Composizioni cooperative sinergiche utili per aumento del tessuto molle, rilascio di farmaco e campi correlati
US20230355511A1 (en) * 2020-09-30 2023-11-09 Tolmar International Limited Biodegradable polymer and solvent compositions and systems for extended storage and delivery of active pharmaceutical ingredients

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5143724A (en) * 1990-07-09 1992-09-01 Biomatrix, Inc. Biocompatible viscoelastic gel slurries, their preparation and use
ITFI980104A1 (it) * 1998-05-04 1999-11-04 Hibiscus S R L Composizioni stabilizzate contenenti acido ialuronico,loro preparazione ed uso
US7582311B1 (en) * 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
AU2002219935A1 (en) * 2000-11-28 2002-06-11 Focal, Inc. Polyalkylene glycol viscosity-enhancing polymeric formulations

Also Published As

Publication number Publication date
NO20073762L (no) 2007-09-14
CA2587388A1 (en) 2006-07-06
KR20070091302A (ko) 2007-09-10
RU2007127835A (ru) 2009-01-27
TW200640496A (en) 2006-12-01
WO2006071694A1 (en) 2006-07-06
US20060140988A1 (en) 2006-06-29
IL184062A0 (en) 2007-10-31
EP1827376A1 (en) 2007-09-05
AU2005322231A1 (en) 2006-07-06
MX2007007826A (es) 2007-07-25
JP2008525471A (ja) 2008-07-17
AR052182A1 (es) 2007-03-07

Similar Documents

Publication Publication Date Title
BRPI0519199A2 (pt) composiÇço de viscossuplemento e uso da mesma
NI201000055A (es) 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa.
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
ECSP088800A (es) Formulaciones de inhibidores de DPP IV
PA8796201A1 (es) Agentes anti-infecciosos y su uso
AR057253A1 (es) Anticuerpos anti-ox40l y metodos que los utilizan
CR20110035A (es) Composiciones y Métodos para Anticuerpos que se dirigen a la Proteína de Complemento C5
DOP2015000264A (es) Derivados de azaadamantano y métodos de uso de los mismos
CR20150088A (es) Anticuerpos anti-notch1 nrr
UY31806A (es) Compuestos de tiazole y oxazole de sulfonamida de benceno
ECSP077316A (es) Compuestos imidazo-3-il-amina bicíclicos sustituidos
CL2010001530A1 (es) Compuestos derivados de tiadiazoliloxifenilamidinas; su procedimiento de preparacion; agentes para combatir microorganismos indeseados que comprende a dichos compuestos; uso; procedimiento para combatir microorganismos indeseados; y compuestos intermediarios.
AR061246A1 (es) Anticuerpos anti- dill4 y metodos que los usan
GT200900292A (es) "inhibidores de cinasa p70 s6"
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
AR057237A1 (es) Metodos y composiciones para actuar sobre la poliubiquitina
BRPI0516483A (pt) preparo e uso de derivados de ácido bifenil-4-il-carbonilamino para o tratamento de obesidade
CU23871B1 (es) Composiciones y métodos de uso para anticuerpos de dickkopf-1
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
CR11861A (es) Compuestos organicos
DOP2010000304A (es) Composiciones y metodos de preparacion y uso de las mismas
ECSP088752A (es) Formulaciones para administración parenteral de compuestos y sus usos
BRPI0609765A8 (pt) mistura de isoalcano, método para a preparação da mesma, composição cosmética ou farmacêutica, e, uso de uma mistura de isoalcano
ECSP11011344A (es) Nuevos anticuerpos anti-?5?1 y sus usos

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]